BioMarin Pharmaceutical | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amgen USD 3.38B 111M 2024-12
Bayer EUR -481000000 805M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
Incyte USD 234.19M 172.64M 2025-03
Insmed USD -234282000 14.77M 2024-12
Ionis Pharmaceuticals USD -147000000 40M 2025-03
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 423.5M 27M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



BioMarin Pharmaceutical Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.